Association of Reproductive Health Professionals
Association of Reproductive Health Professionals
Reproductive Health Topics Publications & Resources Professional Education Newsroom Membership Policy & Advocacy About Us
Annual Meetings
 
Reproductive Health 2010

Reproductive Health 2010

Accreditation | Awards and Lectureships | How will I receive my continuing education (CE) credits? | Faculty and Moderators | Final Agenda | Final Program | Oral and Poster Abstracts | Other InformationPresentations | Virtual Take-One Table

2010 Oral and Poster Abstracts

Oral Abstracts

O01

THE UTILITY OF SONOGRAPHIC ASSESSMENT OF INTRAUTERINE DEVICE PLACEMENT FOLLOWING IMMEDIATE VERSUS DELAYED INSERTION FOLLOWING UTERINE ASPIRATION

O02

TXT NOW 2 DECREASE PREGNANCIES L8R: A RANDOMIZED CONTROL TRIAL TO EVALUATE THE EFFECT OF DAILY EDUCATIONAL TEXT MESSAGES ON ORAL CONTRACEPTIVE CONTINUATION IN YOUNG URBAN WOMEN

O03

THE SAFETY OF DIGOXIN AS A FETICIDAL AGENT

O04

MUSIC AS AN AUXILIARY ANALGESIC DURING FIRST TRIMESTER SURGICAL ABORTION: A RANDOMIZED CONTROL TRIAL

O05

INTRODUCING MEDICAL ABORTION IN NEPAL WITH MINIMAL TECHNOLOGY

O06

A DOUBLE-BLINDED RANDOMIZED TRIAL OF SAME-DAY DILAPAN-S VERSUS OVERNIGHT LAMINARIA FOR CERVICAL PREPARATION BEFORE SURGICAL ABORTION BETWEEN FOURTEEN AND EIGHTEEN WEEKS' GESTATION

O07

EARLY WEIGHT GAIN AND ITS RELATIONSHIP TO LATER WEIGHT GAIN IN ADOLESCENTS ON DMPA

O08

THE IMPACT OF PACK SUPPLY ON ORAL CONTRACEPTIVE CONTINUATION: A RANDOMIZED CONTROLLED TRIAL

O09

DO DEPRESSED MOOD, PSYCHOLOGICAL STRESS AND EATING DISORDERED SYMPTOMS INCREASE THE RISK FOR ORAL CONTRACEPTIVE DISCONTINUATION IN YOUNG MINORITY WOMEN?

O10

DOES CONVENIENCE MATTER? ORAL CONTRACEPTIVE CONTINUATION ALONG THE US-MEXICO BORDER

O11

COMPARISON OF THE INCIDENCE OF PELVIC INFLAMMATORY DISEASE IN INTRAUTERINE DEVICES USERS BY GONORRHEA AND CHLAMYDIA SCREENING STRATEGIES

O12

RATES OF CONTINUATION AND EXPULSION OF INTRAUTERINE CONTRACEPTION AT 12 MONTHS IN NULLIPAROUS AND ADOLESCENT WOMEN

O13

STRUCTURED CONTRACEPTIVE COUNSELING: A RANDOMIZED CONTROLLED TRIAL

O14

CAN PARENTS TEACH THEIR TEENS TO HAVE SAFE SEX? RESULTS OF AN EDUCATIONAL INTERVENTION FOR PARENTS IN MEXICO

O15

RANDOMIZED TRIAL OF HOME VERSUS CLINIC-BASED SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS IN LONG-ACTING REVERSIBLE CONTRACEPTIVE USERS

O16

REVITALIZING LONG ACTING REVERSIBLE CONTRACEPTIVES IN SETTINGS WITH HIGH UNMET NEED:  A MULTI-COUNTRY EXPERIENCE MATCHING DEMAND CREATION AND SERVICE DELIVERY

O17

PROPHYLACTIC MISOPROSTOL PRIOR TO IUD INSERTION IN NULLIPAROUS WOMEN

O18

RESUMPTION OF SEXUAL ACTIVITY AFTER FIRST TRIMESTER SUCTION ASPIRATION

O19 PREGNANCY INTENTIONS AND FAMILY PLANNING PREFERENCES AMONG HIV-INFECTED WOMEN IN NYANZA PROVINCE, KENYA
020 CONTRACEPTIVE AND PREGNANCY OUTCOMES: A RANDOMIZED CONTROLLED TRIAL OF IMMEDIATE VERSUS DELAYED POST-ABORTAL COPPER T 380A IUD INSERTION AFTER SECOND TRIMESTER ABORTIONS
021 STI/PREGNANCY PREVENTION USING TECHNOLOGY-BASED EDUCATION

Poster Abstracts

P01

A RANDOMIZED TRIAL OF IMMEDIATE VERSUS DELAYED INSERTION OF THE COPPER T 380Q FOLLOWING MEDICATION ABORTION

P02

PAIN FOLLOWING POST-ASPIRATION IUD INSERTION

P03

USING QUALITATIVE METHODS TO EXPLORE EC USERS WILLINGNESS TO ACCEPT THE COPPER IUD

P04

TRANSCESAREAN IUD INSERTION: A PROSPECTIVE COHORT STUDY

P05

RATES OF EXPULSION AT 6 MONTHS IN WOMEN UNDERGOING IMMEDIATE POSTABORTION INTRAUTERINE CONTRACEPTION INSERTION

P06

ESTIMATED COST SAVINGS WITH PROVIDING UNIVERSAL CONTRACEPTION IN THE STATE OF OREGON

P07

PREDICTORS OF PATIENT USE OF HIGHLY EFFECTIVE POST-PARTUM CONTRACEPTION

P08

EFFECTS OF ST. JOHN’S WORT ON THE PHARMACOKINETICS OF LEVONORGESTREL IN EMERGENCY CONTRACEPTIVE (EC) DOSING

P09

EVALUATION OF ORAL CONTRACEPTIVE EFFECTIVENESS IN A LARGE COHORT STUDY - IS ELEVATED BMI ASSOCIATED WITH REDUCED ORAL CONTRACEPTIVE EFFECTIVENESS?

P10

COMPARING THE CONTRACEPTIVE DECISION-MAKING OF WOMEN WHO CHOOSE AN INTRAUTERINE DEVICE VERSUS A LESS EFFECTIVE METHOD: A QUALITATIVE ANALYSIS

P11

COMPARING OUTCOMES FOLLOWING IMMEDIATE OR DELAYED LEVONORGESTREL-IUD INSERTION AFTER DILATION AND CURETTAGE, DILATION AND EVACUATION AND VAGINAL DELIVERY

P12

CONTRACEPTIVE USE AMONG WOMEN OBTAINING ABORTIONS IN 2008

P13

COUPLES-BASED FAMILY PLANNING SERVICES: IS THERE A NEED?

P14

LEVONORGESTREL RELEASE RATES WITH LNG20, A NEW LEVONORGESTREL INTRAUTERINE SYSTEM, AND MIRENA

P15

KNOWLEDGE OF CONTRACEPTIVE EFFECTIVENESS AMONG A COHORT OF ST. LOUIS WOMEN CHOOSING REVERSIBLE CONTRACEPTION

P16

PLASMA LEVONORGESTREL LEVELS IN WOMEN USING LNG20, A NEW LEVONORGESTREL INTRAUTERINE SYSTEM, AND MIRENA

P17

CONTINUATION AND SATISFACTION OF REVERSIBLE CONTRACEPTION: A PRELIMINARY ANALYSIS FROM THE CONTRACEPTIVE CHOICE PROJECT

P18

UNDERSTANDING THE ATTITUDES OF BLACK, LATINO, AND WHITE COUPLES TOWARDS STERILIZATION

P19

CARBAMAZEPINE COADMINISTRATION WITH AN ORAL CONTRACEPTIVE: EFFECTS ON STEROID PHARMACOKINETICS, OVULATION AND BLEEDING

P20

WHAT DO WOMEN WANT? WOMEN'S EXPERIENCES AND PREFERENCES ABOUT CONTRACEPTIVE COUNSELING: A QUALITATIVE STUDY

P21

PAIN WITH IUD INSERTION FOLLOWING PROPHYLACTIC IBUPROFEN: A RANDOMIZED TRIAL

P22

US ADOLESCENT EXPERIENCE WITH INTRAUTERINE DEVICE INSERTION AND USE: A RETROSPECTIVE STUDY

P23

EMERGENCY CONTRACEPTION KNOWLEDGE AND LIKELIHOOD OF USE BY WOMEN WITH RECENT POOR PERINATAL OUTCOMES

P24

CONTRACEPTIVE CHOICES IN PATIENTS WITH LOW LITERACY SKILLS

P25

WHAT FACTORS INFLUENCE WOMEN'S CONTRACEPTIVE DECISIONS?

P26

FAMILY PLANNING PROVIDER ATTITUDES AND PRACTICES RELATED TO PROVISION OF CONTRACEPTIVE METHODS AMONG WOMEN WITH VARIOUS CHARACTERISTICS AND MEDICAL CONDITIONS

P27

MEDICAL STUDENT INTRAUTERINE CONTRACEPTION KNOWLEDGE AND ATTITUDES: EVALUATION OF OBSTETRIC AND GYNECOLOGY CLERKSHIP TRAINING

P28

ASSOCIATION OF AGE AND LARC METHOD CHOICE IN THE CONTRACEPTIVE CHOICE PROJECT

P29

UNMET NEED FOR PUBLICLY FUNDED FAMILY PLANNING IN REGION IV

P30

PREVALENCE OF CHLAMYDIA TRICHOMATIS AND NEISSERIA GONORRHOEA IN PATIENTS REQUESTING IUD AS POST ABORTION CONTRACEPTION IN A PUBLICLY FUNDED PREGNANCY TERMINATION CLINIC

P31

GIVING YOUNG WOMEN IN KENYA AN OPPORTUNITY TO USE IMPLANTS INSTEAD OF SHORT-ACTING METHODS: PROSPECTIVE STUDY TO MEASURE ACCEPTABILITY AND BENEFITS

P32

FACTORS ASSOCIATED WITH CHOOSING A LONG ACTING REVERSIBLE CONTRACEPTIVE METHOD AMONGST POSTPARTUM WOMEN IN AN URBAN TEACHING HOSPITAL

P33

EFFECT OF SUBCUTANEOUS DEPO-MEDROXYPROGESTERONE ACETATE SUBCUTANEOUS (DEPOT-MEDROXYPROGESTERONE ACETATE) ON SERUM ANDROGENIC MARKERS IN NORMAL WEIGHT, OBESE AND EXTREMELY OBESE WOMEN

P34

BARRIERS TO CONTRACEPTIVE USE IN TASBA-PRI, NICARAGUA

P35

COMMUNITY-BASED PROVISION OF DMPA IN TIGRAY, ETHIOPIA: TASK SHIFTING TO REACH WOMEN

P36

IUD REMOVALS IN THE EMERGENCY DEPARTMENT SETTING

P37

RATES OF INTRAUTERINE DEVICE DISCONTINUATION AFTER ABORTION VS. INTERVAL PLACEMENT

P38

METHOD SATISFACTION AMONG USERS OF POST PARTUM IUD IN EL SALVADOR

P39

OVARIAN SUPPRESSION IN NORMAL-WEIGHT AND OBESE WOMEN USING A CONTRACEPTIVE VAGINAL RING

P40

OVARIAN FOLLICULAR DEVELOPMENT DURING SIX WEEK EXTENDED USE OF A SINGLE CONTRACEPTIVE VAGINAL RING

P41

CONTINUATION AND ACCEPTABILITY OF THE LEVONORGESTREL INTRAUTERINE SYSTEM AND DEPO-MEDROXYPROGESTERONE ACETATE AMONG ADOLESCENTS AND YOUNG WOMEN

P42

THE EFFECT OF PARITY ON REASONS FOR REMOVAL OF A LEVONORGESTREL IUS

P43

SELF-ADMINISTRATION OF SUBCUTANEOUS DEPOT MEDROXYPROGESTERONE ACETATE BY ADOLESCENT WOMEN

P44

PROVISION OF POSTPARTUM CONTRACEPTION IN WOMEN WITH CHRONIC MEDICAL CONDITIONS

P45

USE OF A SELF-ADMINISTERED COMPUTER MODULE PROVIDING PERSONALIZED CONTRACEPTIVE RECOMMENDATIONS IN A CLINICAL SETTING

P46

COST ANALYSIS OF HYSTEROSCOPIC STERILIZATION VERSUS THE INTRAUTERINE DEVICE AS LONG-TERM CONTRACEPTION

P47

IBUPROFEN PROPHYLAXIS FOR LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM INSERTION: A RANDOMIZED CONTROLLED TRIAL

P48

PROVIDER OPINIONS ABOUT EXPANDING ACCESS TO HORMONAL CONTRACEPTION

P49

NUMBER OF ORAL CONTRACEPTIVE PILL PACKAGES DISPENSED AND SUBSEQUENT UNINTENDED PREGNANCIES

P50

LENGTH OF TIME AFTER INSERTION FOR THE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM FOR IT TO SIGNIFICANTLY ALTER CERVICAL MUCUS QUALITY AND SPERM PENETRABILITY

P51

CONTRACEPTIVE CHOICES OF ADOLESCENTS IN A LARC-ORIENTED ADOLESCENT TITLE X CLINIC

P52

BARRIERS TO POST-PARTUM IUC USE: IMPLICATIONS FOR PATIENT CONTRACEPTIVE PREFERENCES AND SATISFACTION WITH HEALTH SERVICES

P53

THE IMPACT OF INSURANCE COVERAGE ON IUD UTILIZATION

P54

CHARACTERISTICS OF WOMEN WHO FAIL TO RETURN FOR DELAYED IUD INSERTION FOR POST-ABORTION CONTRACEPTION

P55

USE OF EFFECTIVE CONTRACEPTIVE METHODS AMONG WOMEN TAKING TERATOGENIC MEDICATIONS FOR SYSTEMIC LUPUS ERYTHEMATOSUS

P56

ARE THERE DIFFERENCES? SHBG LEVELS, FREE TESTOSTERONE AND SEXUAL PAIN IN WOMEN USING COMBINED HORMONAL CONTRACEPTION: A RETROSPECTIVE STUDY IN VULVODYNIA PATIENTS

P57

PARTNERSHIP CHARACTERISTICS AS PREDICTORS FOR CHOOSING A VERY EFFECTIVE CONTRACEPTIVE METHOD

P58

UNMET DEMAND FOR STERILIZATION AMONG LATINAS

P59

EXAMINING THE INFLUENCE OF MATERNAL CHARACTERISTICS ON THE USE OF CONTRACEPTION AFTER ABORTION IN THE UNITED STATES USING THE 2002 NATIONAL SURVEY OF FAMILY GROWTH

P60

MEDICAL VERSUS SURGICAL ABORTION: THE IMPORTANCE OF WOMEN’S CHOICE

P61

WOMEN'S ATTITUDES AND BEHAVIORS TOWARD UNPLANNED PREGNANCY: A PROSPECTIVE STUDY

P62

CHANGES IN SERVICE DELIVERY PATTERNS AFTER LAUNCHING TELEMEDICINE PROVISION OF MEDICATION ABORTION IN IOWA

P63

HAS MIFEPRISTONE MEDICAL ABORTION EXPANDED ABORTION ACCESS IN NEW MEXICO? A SURVEY OF OB/GYN AND FAMILY MEDICINE PHYSICIANS

P64

REPRODUCTIVE HEALTH PROGRAM: OUTCOMES OF A UNIQUE ABORTION TRAINING PROGRAM

P65

“ARE WE EVEN SPEAKING THE SAME LANGUAGE?”: CONTESTED DEFINITIONS OF RAPE, INCEST, AND LIFE ENDANGERMENT UNDER THE HYDE AMENDMENT

P66

STANDARDIZING EARLY ABORTION COMPLICATION DEFINITIONS AND TRACKING: TESTING AN EVIDENCE-BASED FRAMEWORK

P67

OVULATION RESUMPTION AFTER MEDICAL ABORTION WITH MIFEPRISTONE AND MISOPROSTOL

P68

PRELIMINARY RESULTS OF THE ROLE OF SEMIQUANTITATIVE PREGNANCY TESTS IN MEDICAL ABORTION PROVISION

P69

PREVENTING REPEAT ABORTION: IS THE IMMEDIATE INSERTION OF INTRAUTERINE DEVICES POST-ABORTION ASSOCIATED WITH FEWER REPEAT ABORTIONS IN A CANADIAN POPULATION?

P70

DILATION AND EVACUATION VS. LABOR INDUCTION FOR FETAL INDICATIONS: A RETROSPECTIVE COHORT STUDY

P71

ABORTION PRACTICE AND NEED FOR TRAINING IN MEXICO: RESULTS FROM A SURVEY OF MEXICAN PROVIDERS AT THE 2009 ANNUAL OBSTETRICS AND GYNECOLOGY SPECIALTY CONFERENCE

P72

CONTRACEPTIVE CHOICES OF OVERWEIGHT AND OBESE WOMEN IN A PUBLICALLY FUNDED HOSPITAL: CLINICAL IMPLICATIONS

P73

IMPACT OF GESTATIONAL AGE ON PAIN PERCEPTION DURING FIRST TRIMESTER SURGICAL ABORTION

P74

IMPACT OF A SPECIALTY ROTATION IN FAMILY PLANNING ON OBSETRICS AND GYNEOCLOGY RESIDENTS' SELF-ASSESSMENT OF COMPETENCY AND INTENTIONS TO PROVIDE ABORTION SERVICES AFTER GRADUATION

P75

THE EXTENDED GESTATIONAL AGE MEDICAL ABORTION STUDY: THE EFFECTIVENESS OF MEDICAL ABORTION WITH MIFEPRISTONE AND MISOPROSTOL AT 57-63 DAYS VERSUS 64-70 DAYS GESTATION

P76

MUSIC IN SURGICAL ABORTION CARE: A RANDOMIZED CONTROLLED PILOT STUDY

P77

CAN THE PROSPECT OF INFERTILITY MOTIVATE YOUNG WOMEN'S INTENTIONS TO SEEK PREVENTIVE HEALTHCARE? FINDINGS FROM CDC CONCEPT TESTING FOCUS GROUPS

P78

HIGH-RISK SEXUAL BEHAVIOUR IN A RANDOM SAMPLE OF >22,000 MEN FROM THE GENERAL POPULATION IN DENMARK

P79

EXPERIENCES OF DISCRIMINATION AND STI TESTING IN WHITE AND BLACK WOMEN

P80

MISSED OPPORTUNITIES FOR CHLAMYDIA RETESTING AT LIMITED SERVICE VISITS IN CALIFORNIA FAMILY PLANNING CLINICS

P81

THE BABOON (PAPIO ANUBIS) AS A NOVEL MODEL OF CHLAMYDIA TRACHOMATIS PELVIC INFLAMMATORY DISEASE FOR TESTING INTRAUTERINE CONTRACEPTION

P82

IMIQUIMOD 2.5% AND 3.75% APPLIED DAILY FOR UP TO 8 WEEKS TO TREAT EXTERNAL GENITAL WARTS

P83

ELDERLY PERSON'S REPRODUCTIVE HEALTH CHALLENGES AND INVOLVEMENT IN RISKY SEXUAL ACTIVITIES IN IKORODU, NIGERIA

P84

PREDICTORS OF SEXUAL SATISFACTION AMONG YOUNG ADULTS IN THE UNITED STATES

P85

REPRODUCTIVE AND SEXUAL HEALTH IN MENTALLY ILL

P86

SEXUAL INTIMATE PARTNER VIOLENCE, SEXUAL RISK BEHAVIORS, AND CONTRACEPTIVE PRACTICES AMONG WOMEN OF AFRICAN DESCENT

P87

REPRODUCTIVE HEALTHCARE NEEDS OF HIV-POSITIVE WOMEN

P88

CONTRACEPTIVE KNOWLEDGE, ATTITUDES, AND PRACTICES AMONG HIV-INFECTED WOMEN AND MEN RECEIVING HIV CARE AND TREATMENT IN NYANZA PROVINCE, KENYA

P89

HIGH CONTRACEPTION USE AND LOW PREGNANCY RATE AMONG HIV POSITIVE WOMEN ATTENDING A POSTNATAL PROGRAM IN LILONGWE, MALAWI

P90

INTRAUTERINE LIDOCAINE INFUSION FOR PAIN MANAGEMENT DURING OUTPATIENT TRANSCERVICAL TUBAL STERILIZATION

P91

RISK FACTORS FOR AND CONSEQUENCES OF UNINTENDED PREGNANCY AMONG LATINA AND WHITE POPULATIONS IN UTAH, 2004-2007

P92

COMPARISON OF LNG20, A NEW LEVONORGESTREL INTRAUTERINE SYSTEM, AND MIRENA FOR TREATMENT FOR MENORRHAGIA

P93

PRESUMPTIVE TREATMENT OF ABNORMAL EARLY PREGNANCY OF UNKNOWN LOCATION

P94

VAGINAL AND RECTAL CLOSTRIDIAL COLONIZATION AMONG WOMEN OF REPRODUCTIVE AGE IN THE UNITED STATES

P95

TWO-STAGE CLUSTER SAMPLING WITH REFERRAL: IMPROVING THE EFFICIENCY OF ESTIMATING UNMET NEEDS AMONG PREGNANT AND POSTPARTUM WOMEN AFTER FLOODING IN NORTHWEST GEORGIA, SEPTEMBER 2009

P96

RURAL REPRODUCTIVE HEALTH: BARRIERS AND FACILITATORS EXPERIENCED BY LOW-INCOME RURAL WOMEN IN OBTAINING REPRODUCTIVE HEALTH CARE SERVICES

P97

EFFECT OF A "CONTRACEPTIVE VITAL SIGN" IN PRIMARY CARE: A RANDOMIZED CONTROLLED TRIAL

P98

ASSOCIATION BETWEEN ECONOMIC VULNERABILITY AND WOMEN'S PREGNANCY INTENTIONS

P99

IMPACT OF LENGTH OF FORMAL FAMILY PLANNING TRAINING ON SELF-ASSESSED COMPETENCE AND PROCEDURE VOLUME OF ABORTION PROCEDURES

P100

IMPACT OF FORMAL FAMILY PLANNING TRAINING ON OB-GYN RESIDENTS SKILLS AND EXPOSURE IN CONTRACEPTION PROVISION

P101

INNOVATION IN EMERGENCY OBSTETRIC TRAINING, PRONTO2: AN IN SITU MULTI-DISCIPLINARY, LOW-TECH, HIGH-FIDELITY SIMULATION-BASED CURRICULUM FOR MEXICO, RESULTS OF A PILOT IMPLEMENTATION STUDY

P102

CONTRACEPTION USE AFTER AN UNPLANNED PREGNANCY